发明名称 |
Assays for compounds which increase phospholipase a2 activity |
摘要 |
A method of identifying a compound which increases the activity of a phospholipase A2 towards a given phospholipid substrate the method comprising determining whether the activity of phospholipase A2 towards the given substrate is increased in the presence of a compound compared to its activity in the absence of the same compound. A method of identifying a compound which increases the production or expression of phospholipase A2 in a cell the method comprising determining directly or indirectly whether the production or expression of phospholipase A2 in a cell is increased in the presence of a compound compared to its production or expression in the absence of the same compound. A method of treating a psychiatric or neurological disorder such as depression in a patient the method comprising administering an effective dose of a compound which increases the release of docosahexaenoic acid from brain membrane phospholipids. A method of identifying a compound which mimics the effect of docosahexaenoic acid on the glucocorticoid receptor the method comprising contacting the glucocorticoid receptor with a compound and determining whether the compound has substantially the same effect as docosahexaenoic acid on the glucocorticoid receptor. |
申请公布号 |
AU1971200(A) |
申请公布日期 |
2000.06.26 |
申请号 |
AU20000019712 |
申请日期 |
1999.12.07 |
申请人 |
KNOLL AKTIENGESELLSCHAFT |
发明人 |
DAVID JOHN HEAL;KEITH FRANK MARTIN;KEVIN STUART JOHN THOMPSON |
分类号 |
G01N33/50;A61K31/00;A61K31/202;A61K45/00;A61P25/08;A61P25/18;A61P25/22;A61P25/24;A61P25/28;C12N9/16;C12N15/09;C12Q1/02;C12Q1/44;C12Q1/66;C12Q1/68;G01N33/15;G01N33/68;G01N33/74;G01N33/92 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|